Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
Conditions: Chordoma; Locally Advanced Chordoma; Metastatic Chordoma; Unresectable Chordoma Interventions: Biological: Nivolumab; Biological: Relatlimab Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Chordoma